CanSino Biologics Inc (CJH) — Net Asset Quality Index
CanSino Biologics Inc (CJH) has a Net Asset Quality Index of 69.0% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €7.18 Billion minus total liabilities of €2.22 Billion yields net assets of €4.95 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are CanSino Biologics Inc's assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
CanSino Biologics Inc Net Asset Quality Index Over Time (2016–2025)
This chart shows how CanSino Biologics Inc's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the index stands at 69.0%, representing net assets of €4.95 Billion against total assets of €7.18 Billion EUR. See CJH working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for CanSino Biologics Inc (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for CanSino Biologics Inc from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is CanSino Biologics Inc worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 69.0% | €4.95 Billion | €7.18 Billion | €2.22 Billion | ▲ +7.3 pp |
| 2024 | 61.7% | €4.91 Billion | €7.96 Billion | €3.05 Billion | ▲ +5.0 pp |
| 2023 | 56.7% | €5.29 Billion | €9.32 Billion | €4.03 Billion | ▼ -6.4 pp |
| 2022 | 63.2% | €7.25 Billion | €11.47 Billion | €4.22 Billion | ▼ -8.8 pp |
| 2021 | 72.0% | €8.55 Billion | €11.87 Billion | €3.33 Billion | ▼ -18.0 pp |
| 2020 | 90.0% | €6.07 Billion | €6.75 Billion | €677.22 Million | ▲ +7.6 pp |
| 2019 | 82.4% | €1.47 Billion | €1.78 Billion | €313.98 Million | ▲ +19.3 pp |
| 2018 | 63.1% | €502.32 Million | €795.88 Million | €293.56 Million | ▼ -7.0 pp |
| 2017 | 70.1% | €607.33 Million | €866.36 Million | €259.03 Million | ▲ +4.3 pp |
| 2016 | 65.8% | €214.47 Million | €326.17 Million | €111.70 Million | — |